40: A Shot at Love with Nonprofit Insulin
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
40: A Shot at Love with Nonprofit Insulin
-
Narrated by:
-
Written by:
About this listen
Nonprofit pharmaceutical company Civica has released it's biosimilar version of Lantus long-acting insulin for $55 for a box of 5 pens—that's the list price it costs you to buy it without needing insurance, coupons, or patient assistance programs. We look at how a nonprofit business model can drastically lower prices for patients and governments.
Things we talk about:
-
More info about Civica insulin and CalRx Insulin
-
CalRx Patient Advisory Council Charter
-
Episode on insulin pricing
-
Episode on co-pay cap laws
-
119th Congress pro-healthcare scorecard
Support Beta Cell on Patreon.
No reviews yet